Skip to content

To evaluate the efficacy of Polyherbal Ayurveda medicine Bahushala Guda and Chitraka Haritaki in Allergic Rhinitis

Randamized control clinical trial to evaluate the efficacy of bahushala guda and chitraka haritaki in vataja pratishyaya with special reference to allergic rhinitis - Nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083915
Enrollment
40
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

None listed

Sponsors

JSS Ayurveda Medical College and Hospital , Mysuru
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 3 to 12 years will be selected irrespective of gender, occupation, religion & socio-economic status. 2.Children fulfilling diagnostic criteria of Vataja Pratishyaya. 3.Children whose parents are willing to give informed assent

Exclusion criteria

Exclusion criteria: 1. Known cases of systemic disorder which may interfere with course of study 2.Known cases of any congenital anomalies which may interfere with course of study 3.Children who are on any other antiallergic medications 4.Subjects with Nasal polyp, Epistaxis and previous history of surgery for Nasal and paranasal sinuses are excluded 5. Subjects with tonsillitis

Design outcomes

Primary

MeasureTime frame
Bahusala guda is efficient in vataja pratishyaya in comparision to chitraka haritakiTimepoint: on 14th day of trial

Secondary

MeasureTime frame
chitraka haritakiis efficient in vataja pratishyaya in comparision to Bahusala gudaTimepoint: on 14th day of trial

Countries

India

Contacts

Public ContactDr Srihari S

JSS Ayurveda Medical College and Hospital , Mysuru

dr.srihari@rediffmail.com7776077626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026